CHA Hospital Group
CHA Hospital Group, which started as CHA Obstetrics and Gynecology in 1960, opened the era of Korea’s first specialized hospital in 1984 when CEO Cha Gwang-ryeol established Gangnam CHA Hospital. In the 1980s, Gangnam CHA Hospital and the Women’s Medical Research Institute pioneered infertility research, which was minimal in Korea, and gained global recognition for infertility and reproductive medicine as it was introduced in American textbooks and Time magazine. He established Bundang CHA Hospital in 1995, Gumi CHA Hospital in 1999, and CHA University. In the 2000s, he established a hospital in Los Angeles, USA, an advanced medical country, thereby raising the status of Korean medicine.
In addition, the bio research company CHA Biotech was established to lay the foundation for the development of blockbuster cell therapy products.
In 2010, CHAUM, known as a new model of future medicine, was established and solidified the status of a global CHA hospital in the world. In 2014, Japan Cha Hospital Tokyo TCC was established and is recognized as the only medical institution in Korea that has expanded into both the United States and Japan, which are medically advanced countries in name and reality. In addition, we established CHA Bio Complex, a futuristic research institute where industry, academia, and research can create new bio drugs through practical convergence and exchange, and declared our entry into the bio industry. In 2015, we established Asia’s largest ‘CHA Hospital Women’s Medical Research Institute Seoul Station Center’ to lead global infertility treatment and present a new model for a future infertility center. CHA Medical Group is constantly challenging its dream of becoming the global No. 1 medical group.